Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Out-licensing

Decapinol Toothpaste - Intelligent treatment for gingivitis & prevention of periodontitis

Sinclair Pharmaceuticals
Decapinol toothpaste containing Sodium Fluoride (NaF) 0.11% and Delmopinol 0.2% is a new addition to the Decapinol family and is indicated for the treatment of gingivitis and periodontitis.

Mechanism of action

Decapinol Toothpaste's key ingredient Delmopinol prevents the attachment as well as the adherence of plaque bacteria to the teeth, gingiva and to itself, which prevents the onset of gingivitis.

Full description

Decapinol toothpaste containing Sodium Fluoride (NaF) 0.11% and Delmopinol 0.2%, is a new addition to the Decapinol family and is indicated for the treatment of gingivitis and periodontitis.

Decapinol toothpaste is designed as a preventative measure and complements Decapinol rinse extremely well and as with the rinse, this new presentation contains the cationic surfactant Delmopinol Hydrochloride.

Decapinol Toothpaste's key ingredient ~ Delmopinol, has a unique mode of action, which prevents the attachment as well as the adherence of plaque bacteria to the teeth, gingiva and to itself . This interference with the plaque build-up process prevents the onset of gingivitis that can lead to periodontitis.

It also interferes with the enzyme GTF, which is responsible for the production of glucans (the glue or cement that is critical for plaque build-up). This results is less cohesive and less adhesive plaque bacteria, making it easier to remove by conventional tooth brushing techniques.

It also maintains a healthy composition of oral bacteria .

Decapinol Toothpaste and Toothpaste (gel) with Fluoride (0.11%) contains 2mg Delmopinol hydrochloride per ml and is available in a 75ml PE tube and a 16ml sample tube.

Core benefits -

  • Decapinol toothpaste offers a convenient way to treat and prevent gingivitis & periodontitis ~ it allows patients to help control gingivitis in an easy and convenient manner
  • Delmopinol molecule has proven efficacy & safety in treating gingivitis - short & long term
  • Customer satisfaction & compliance - does not cause tooth staining so long-term use
  • Delmopinol promotes healthy balance of oral microflora - does not kill gram-positive bacteria (associated with healthy gingiva) unlike Chlorhexidine based toothpaste/toothgels
  • Decapinol Toothpaste compliments Decapinol Rinse very well and both can be used in conjunction with each other

Stage of development

In the European Union, Decapinol Toothpaste Fluoride and Decapinol Toothpaste (gel) fluoride is registered as a Class IIa medical device, and has as such been awarded a CE mark. The Medical Device Directive applies to all European Union countries, which means the above can be sold freely within these countries, without further registration requirements. The CE mark signifies the product's conformity with the Directive.

In the United States, we are currently awaiting approval from the FDA - note, the formulation will differ from the European formulation (more details can be provided upon request).

Development status

Registered

Patent information

Patents pending - Please refer to Sinclair's Business Development team for an update on Decapinol IP situation.

 

 

Type of business relationship sought

Marketing companies are required to sell Decapinol in key territories around the world.

Licensing contact

Javier Boza
Global Business Development Director
Request more information

More information

For more information about the product please visit website.

Company details

Sinclair Pharmaceuticals
Sinclair Pharma plc, a rapidly growing UK based pharmaceutical company is seeking distributors around the world.

Related reports

Are you looking for reports related to this particular subject. Our Reports section is the best place to start.

Related items

Related categories

Partnering consultation free of charge
Bio-Europe 2008
Clinical Outsourcing World
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us